PDA

View Full Version : General Cancer News

Pages : 1 2 3 4 5 6 7 8 9 [10] 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51
  1. GTx reacquires full rights to Ostarine
  2. YM BioSciences: Two posters on nimotuzumab accepted for presentation at AACR
  3. Metastatic melanoma: Involvement of immune system in response to PV-10 therapy
  4. CytRx plans five Phase 2 clinical trials with oncology drug candidates
  5. Hundreds of free diabetes recipes
  6. Gene defects that cause some bowel cancers could become targets for new personalised
  7. Houston scientists unveil new technique for growing 3-D cell cultures
  8. Study offers new possibilities for breast and other cancer therapies
  9. Women who undergo yearly mammography screening have lower rate of palpable tumors
  10. Critical need for second NCI: Sylvester Comprehensive Cancer Center launches campaign
  11. Dual role of Notch signalling pathway
  12. National Breast Cancer Foundation receives over $0.5M as donation from ACE Cash Expre
  13. External beam radiotherapy device without shielded bunker infrastructure for breast c
  14. Cryotherapy offers potential treatment options for breast cancer patients
  15. Key cellular defect in protein synthesis can lead to cancer susceptibility
  16. Cancer news coverage should also focus on hospice and end-of-life care
  17. Pathway Genomics' personal Genetic Health Report now available
  18. Case management funds breast cancer screening and diagnostic services for low-income
  19. Circulating tumor cells could help guide treatment and improve quality of life for ca
  20. Clarient's Ovotax test may help improve patients’ response to taxane therapy
  21. HDC, SPM enter into development and licensing agreements with Quest Diagnostics
  22. Abraxis BioScience's Phase 3 trial comparing ABRAXANE with Taxol injection meets prim
  23. Agendia to participate in groundbreaking clinical trial for breast cancer
  24. I-SPY 2: The Biomarkers Consortium launches clinical trial for high risk, fast-growin
  25. iVillage launches new Health site to help women manage their health needs online
  26. InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%
  27. ETP highlights current Epilepsy Therapy Pipeline at 2010 Epilepsy Pipeline Update Con
  28. Abstract about Phase I/II trial of ThermoDox in RCW accepted for presentation at ASCO
  29. ZIOPHARM Oncology reports net income of $1.0M for quarter ended December 31, 2009
  30. Solos Endoscopy secures U.S. Trademark for MammoView name
  31. ASCO Scientific Program 2010: Provectus Pharmaceuticals' Phase 2 data on PV-10 accept
  32. Rates of breast cancer occurrences in Asian women rising among specific ethnic groups
  33. Major study shoots for personalized breast cancer drugs
  34. Associates of AimLoan.com announces donation of $31,680 to Susan G. Komen for the Cur
  35. Breast cancer survivors at increased risk of developing second cancer: Study
  36. Aqua Sphere organizes event to raise funds and awareness for breast and prostate canc
  37. Global breast cancer organization recognizes Northeast Ohio Affiliate of Susan G. Kom
  38. Cancer radiotherapy can increase risk of cardiovascular disease later in life
  39. GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer
  40. CTI's pixantrone trial for relapsed/refractory aggressive NHL: FDA ODAC finds data in
  41. Skin sparing mastectomy procedures under-utilized in the U.S.
  42. BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine
  43. Merck Serono, EMD Serono suspend global clinical development program for Stimuvax tem
  44. Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds foll
  45. Analgesics can decrease risk of breast or ovarian cancer
  46. PBCC supports passage of health care legislation
  47. Bergen research group adopts nanotechnology for cancer research
  48. Patients and doctors' views on important endpoints in incurable metastatic breast can
  49. Fertility remains a significant issue for majority of breast cancer patients
  50. Agendia brings new personalized treatment for breast cancer patients
  51. China’s 3rd Annual Asia Scientific Congress programs feature latest updates on cancer
  52. Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen
  53. Women from poor backgrounds have worse breast cancer outcomes
  54. Scott & White seeks breast cancer patients for Phase II clinical trial
  55. ScinoPharm announces record results for fiscal year 2009
  56. Tips offered in April 2010 issue of American Journal Of Pathology
  57. Palex Medical to distribute Genomic Health's Oncotype DX breast cancer test in Spain
  58. Independent DMC recommends continuance of enrollment in Eisai's Phase III ACCESS tria
  59. New gateway may be lifesaver for patients with AML: Study
  60. Changing drug therapy can help breast cancer patients get full benefit of tamoxifen t
  61. Pregnancy safe for breast cancer survivors, says study
  62. Pregnant breast cancer patients can receive chemotherapy without endangering baby hea
  63. Complex relation between breastfeeding, prolactin and breast cancer
  64. Two separate articles describing preclinical data of ACE-041 published
  65. False perception of increased risk induces women with breast cancer have prophylactic
  66. Adjuvant systemic must be considered for treatment of primary breast cancer and recur
  67. Informing young women surviving breast cancer about opportunities to have children
  68. American Academy of Actuaries to work with regulatory authorities to enhance quality
  69. Stuidy finds 15-year outcomes of BCT and mastectomy similar
  70. Presence of protein PARP in tumours may help predict response to chemotherapy
  71. Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracy
  72. Treatment with beta-blockers can help reduce spread of cancer in patients with breast
  73. Survival rate is improving in HER2 positive breast cancer patients
  74. Californian healthcare advocates applaud healthcare victory and call for passage of S
  75. Survival improving in patients with HER2 positive metastatic breast cancer
  76. Innovative biotechnology leading to better understanding of complex diseases
  77. Genome sequencing of tumors biopsied from women with invasive breast cancer
  78. Studies shed light on treatment options for women carrying BRCA1 and BRCA2 genetic mu
  79. Presence of PARP protein in tumours can help predict their response to chemotherapy
  80. Biophotonics: Light to cure disease
  81. Lymph node radiotherapy well-tolerated after mastectomy or breast conserving surgery
  82. Erbitux can now be used in Japan as 1st-line treatment for mCRC: Merck Serono
  83. Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patien
  84. Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial
  85. Gene expression in breast tissue may help explain pregnancy-associated breast cancer
  86. CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for
  87. Kylie Minogue supports breast cancer initiative
  88. Systemic treatment of microRNA therapeutic targeting miR-10b inhibits breast cancer m
  89. Breast cancer patients undertreated, essential radiation after mastectomy not perform
  90. Court rules certain claims covering isolated DNA sequences in patents covering BRACAn
  91. Beta-blockers can reduce cancer spread in patients with breast tumours
  92. Eisai seeks simultaneous approval of eribulin mesylate in U.S., EU and Japan
  93. EvoLife Laboratories introduces cancer care products in USA
  94. Devicor offers to acquire EES Breast Care business
  95. Benefits outweigh risks associated with breast cancer screening
  96. Fourth biennial BHGI Global Summit on International Breast Health
  97. Eisai Europe seeks EMA approval of eribulin mesylate for locally advanced or metastat
  98. DSMB for DIGNITY trial recommends Celsion continue enrollment
  99. FDA clears AdvanDx' 90 minutes protocol for C. albicans PNA FISH and C. albicans/C. g
  100. ViroPharma initiates Phase 2 clinical study to evaluate Cinryze
  101. Court rules against gene patents
  102. New medicines in development to fight diseases of particular concern to African Ameri
  103. Positive results from Phase 2 clinical trial of OMS103HP
  104. Link between occupational exposures and postmenopausal breast cancer
  105. Canadians can join Canadian Cancer Society in the fight against cancer
  106. Biotech Posts Strong First Quarter Gain
  107. Extending breast cancer screening to younger women will benefit in terms of economic
  108. UVA's DMT scanner helps detect breast cancer undetectable with mammography, MRI or ne
  109. 2010 Internal Medicine conference at Toronto Convention Center
  110. DNA patent case: US District Judge rules in favor of AMP
  111. Cancer Prevention Coalition submits petition on imminent health hazard from hormonal
  112. Cancer Prevention Coalition statement on new nominated NCI Director
  113. RPCI researcher receives grant to explore link between race and breast cancer
  114. Study could aid in developing new, effective treatments for prostate cancer
  115. Identification and elimination of cancer stem cells
  116. Cancer research at Georgia Tech: Report
  117. Increased risk of ovarian cancer linked to Western Swedish mutation in women with bre
  118. NHS cancer patients to receive latest and best treatments available
  119. Exposure to certain chemicals may lead to early pubertal development
  120. Occupational exposure to synthetic fibers – a possible link with breast cancer
  121. Childhood cancer survivors may not survive long says new study
  122. Study finds link between BRCA mutations and contralateral breast cancer
  123. OICR invests $415,000 to develop radiolabelled insulin probe for early detection of b
  124. New study shows utility of Chronix Biomedical's serum DNA tests in MS
  125. African-American women with advanced breast cancer have poorer survival rates
  126. Folate increases risk of breast cancer in women with certain genetic make-up
  127. Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of brea
  128. Jazzercise, Back in the Swing USA partner to promote breast cancer survivorship progr
  129. Women living in northeastern U.S. more likely to develop RA: Study
  130. Pair of proteins excreted in urine could lead to earlier diagnosis of kidney cancer:
  131. Prague hosts 12th European Congress of Endocrinology
  132. Martina undergoing therapy for breast cancer, urges women to be more vigilant
  133. OSU-CG12 agent kills cancer cells through energy restriction: Study
  134. Individuals should act now to prepare for major tax hikes: Kahler Financial Group
  135. Hospital TV remotes are potential reservoir of bacteria
  136. Merge Healthcare to exhibit expanded suite of women's imaging solutions at NCBC 2010
  137. ZIOPHARM Oncology commences Phase I/II study of Zybulin for metastatic breast cancer
  138. Abraxis BioScience to present updated survival findings from ABRAXANE Phase I/II tria
  139. Gamma-tocotrienol kills prostate tumour cells in animal model studies
  140. Labour’s cancer leaflet campaign questioned
  141. Three in ten women use letrozole to treat infertility: Study
  142. Research opens way for development of new preventions and treatments for breast cance
  143. Three nonprofit organizations launch campaign to increase national awareness of PF
  144. Global study shows wide variations in treatment of women with early breast cancer
  145. Results of Phase I ThermoDox dose escalation trial to be discussed in a press confere
  146. Drinking during adolescence increases risk of benign breast disease in young women
  147. Despite international guidelines, wide variations exist in breast cancer care
  148. Study of yoga for treating women with breast cancer awarded over $4.5M
  149. Javelin Pharmaceuticals intents to terminate Merger Agreement with Myriad Pharmaceuti
  150. ABRAXANE accepted for restricted use within Scotland NHS
  151. American Lung Association's report examines lung cancer among African Americans
  152. Over 17,000 scientists convene at AACR 101st Annual Meeting 2010
  153. Australian scientists sequence genome of pancreatic cancer
  154. Breast Cancer Research: Thinner girls may be at higher risk of breast cancer
  155. ErbB3 program development candidate selection triggers $5M milestone payment to AVEO
  156. ICGC: New era of personalised medicine for cancer patients
  157. New technique improves cosmetic breast reconstruction in athletic cancer patients
  158. New data from Pfizer Oncology's pipeline to be presented at AACR 2010
  159. Genomic component playing key role in promoting breast cancer progression discovered
  160. Scientists uncover new genes responsible for cancer, deafness
  161. Decoding genomes from 25,000 cancer samples
  162. Complete Women's Imaging selects Merge Healthcare as IT partner
  163. Study links cancer growth to sugar-based modification found naturally in the body
  164. Research may help develop simplified test for early detection of breast cancer
  165. Four-protein complex provides new target for thwarting cancer migration, invasion
  166. UALR researcher receives $77,000 federal grant to track estrogen-mimicking compounds
  167. Celsion announces presentation of long-term follow-up data from Phase I ThermoDox dos
  168. Many women with invasive breast cancer unaware about skin-sparing mastectomy
  169. Study: Circadian’s anti-cancer therapy reduces tumour growth in animal models
  170. Federal report details health care quality across states; Online system ranks quality
  171. Diagnosis errors have put patient health in danger: NPSA study
  172. Dance-based therapy can improve balance and gait, and reduce falls in older persons
  173. Role of race and health insurance status in breast cancer diagnosis and treatment
  174. MiRNA-21 interferes with Herceptin therapy, says study
  175. Pre-clinical data on MM-121 and MM-111 to be presented at AACR 2010
  176. CCS organizes Women's Brunch on breast cancer screening
  177. Teen drinking increases the risk for breast cancer
  178. Role of lactate in breast cancer development to be showcased at AACR 2010
  179. Leona Fields honoured for exceptional leadership as New Run Director for York Region
  180. Clues to molecular markers on breast tumors that may predict spread of lymph node can
  181. Study shows long-term effect of vitamins and calcium supplements in breast cancer red
  182. Radiolabeled hedgehog can differentiate stem-like cancer cells and identify aggressiv
  183. Study reveals increased risk for cancer among Latino populations
  184. Mylan Pharmaceuticals introduces 50 mg and 200 mg Clozapine Tablets USP
  185. Weeklong, 60-mile breast cancer fundraising walk in Spain
  186. Myriad Pharmaceuticals terminates merger agreement with Javelin Pharmaceuticals
  187. Raloxifene, tamoxifen remain effective options in prevention of breast cancer, finds
  188. Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combinatio
  189. CINJ: Common genetic variation impacts diagnosis of breast cancer in postmenopausal w
  190. Global guidelines for testing regimes for breast cancer patients
  191. Striking down breast cancer related gene patent may not impact industry, says New Yor
  192. RANKL inhibition may prove effective in treatment of human malignancy, suggests study
  193. Researchers: Breast cancer prevention and treatment protocols not always clear
  194. NEDD9 protein plays significant role in development of HER2-driven breast cancer: Res
  195. USPTO issues patent covering method of metastatic breast cancer treatment using Biono
  196. Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress
  197. High BMI can raise risk of postmenopausal breast cancer
  198. ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple
  199. Montgomery Breast Center of Montgomery installs GammaLoc system for biopsy procedures
  200. EMEA PDCO recommends Cell Therapeutics to submit updated Pediatric Investigation Plan
  201. miRNAs may generate new insights on cancer and possible future treatments
  202. Silence Therapeutics, AstraZeneca announce one-year extension of ongoing siRNA delive
  203. Regence takes action to prevent gap in health care coverage
  204. Decrease in breast density linked to reduced risk of breast cancer
  205. Plexxikon presents promising preclinical data from PLX3397 in vivo cancer studies
  206. Vitamin D intake from foods, supplements may not predict relationship between cancer
  207. Findings may illuminate how cancer forms and migrates
  208. EGFR levels may help early detection of breast cancer
  209. Clarient Insight Dx Pulmotax assay helps predict response to chemotherapy in lung can
  210. Alchemia’s HyACT tumour targeting technology enhances killing of cancer stem cells
  211. Investment report on Array BioPharma
  212. Mammographic density is one of the strongest predictors of breast cancer risk: Resear
  213. Study links mutations in RAD51C gene to breast and ovarian cancer
  214. Manhattan Scientifics' early cancer detection technology offers better results than m
  215. AstraZeneca HealthCare Foundation's cardiovascular health program receives $25M chari
  216. Increase in mammographic density associated with increase of breast cancer in EPT stu
  217. Helen F. Graham Cancer Center at Christiana Care receives $2.8M to extend cancer rese
  218. Report: Wellpoint targets breast cancer patients with policy rescissions
  219. Aragon Pharmaceuticals raises $22M through Series B financing
  220. RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC
  221. Florida's Health Care Freedom Act receives approval
  222. Biological activity of Curis' CUDC-101 HDAC, EGFR and HER2 inhibitor published in Can
  223. Waxman Foundation honors molecular biologist Alan Ashworth with the David T. Workman
  224. Travel Toward Wellness specializes in women's wellness travel for cancer survivors
  225. Transposagen Biopharmaceuticals announces new TGEM Rat Model product line
  226. Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive sto
  227. Detroit-area resident pleads guilty in fraudulent medical testing scheme
  228. Essilorl's first-quarter 2010 consolidated revenues up 7.8%
  229. Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010
  230. Additional training may benefit physicians who interpret screening mammograms
  231. Funding levels need to be increased in fight against malaria
  232. Pelosi responds to reports of WellPoint dropping coverage for breast cancer patients
  233. Crystal structures of key fluorescent proteins to "light up" molecules in cells deter
  234. First Edition: April 23, 2010
  235. Reuters: Wellpoint targets breast cancer patients for rescission
  236. Environmental factors may play bigger role in tumor development: BIDMC study
  237. HHS Secretary urges WellPoint to end harmful practice of dropping health insurance co
  238. BCA calls out KFC and Susan G. Komen for the Cure for egregious pinkwashing campaign
  239. McGill researchers receive $1.7M for 10 cutting-edge research projects
  240. WellPoint responds to HHS letter on singling out women with breast cancer for resciss
  241. Myths and facts about pediatric cancer
  242. Ethnic differences in genetic factors may affect susceptibility to development of bre
  243. DeCODE scientists discover common SNPs that increase number of CPD and risk of lung c
  244. Mothers with preeclampsia at reduced risk of developing breast cancer
  245. Wellcare faces allegations about director's resignation; Wellpoint confronts reports
  246. New report on women's largest cancer challenge: lung cancer
  247. New DaVita Phosphorus Challenge tool for CKD and dialysis patients
  248. Phase I clinical trial results of AE37 in prostate cancer patients presented at EAU C
  249. Dietary MSC can help reset cell's biological clock to prevent development of breast c
  250. NCCTG to conduct Phase II study of brostallicin in combination with cisplatin for mTN